Dear Sir, The paradoxical occurrence of both bleeding tendency and thrombotic complications in advanced renal failure is still an enigma and, therefore, a problem of continued interest. Hemostatic alterations in renal failure are certainly complex and involve abnormal platelet function [1] , increased release of vascular prostacyclin [2] , impaired release of plasminogen activator [3] , and abnormalities in Factor VΠI-von Willebrand complex [4] . Low levels of circulating antithrombin III (AT III) have also been reported [1] . Recently, Alegre et al. [5] reported a decrease in im-munoreactive protein C during hemodialysis and suggested that this may contribute to the prothrombotic state observed in these patients. As a part of a continued research program dealing with the hemostasis in uremia, we have investigated im-munoreactive protein C and protein C activity in patients with progressive renal failure, patients on hemodialysis, and healthy controls. Protein C antigen was measured by Laurell rocket immunoelectrophoresis, the protein C activity was determined according to Francis and Patch, with a pool of plasma from 30 healthy males used as calibrant in both assays, as previously described in detail [6] . We studied 14 hemodialysis patients and 21 healthy controls. Values before and after hemodialysis were compared with Wil-coxon's test of paired differences. Values from patients and controls were further compared with the Mann-Whitney test. The results are summarized in table I. Table I . Plasma protein C antigen levels and activity (arbitrary units) in 21 healthy controls and 14 hemodialysis patients before and after dialysis Immunoreactive protein C was normal both before and after hemodialysis. In contrast, protein C activity was depressed both before and after hemodialysis (p < O.01), although the activity increased after dialysis compared with predialysis values (p < 0.01). Only a minor, however significant, increase in immunoreactive protein C was noticed in the present study during dialysis (p < 0.02). The present results confirm and extend our previous findings regarding changes in immunoreactive protein C and protein C activity in renal failure and during hemodialysis [6, 7] . We have earlier found a decreasing protein C activity with progressive renal failure [7] and a low activity, despite normal antigen levels, in hemodialysis patients [6] , pointing to the existence of a hitherto unknown inhibitor of protein C in uremic plasma. Our results further suggest that this inhibitor may be removed, at last partly, by hemodialysis. 336 Knudsen/Sørensen/Nielsen/Dyerberg Alegre et al.
[5] observed a decrease in immunoreac-tive protein C during hemodialysis. This is in contrast to our finding of a minor increase in protein C antigen levels during hemodialysisan alteration which undoubtly reflects hemoconcentration during the treatment. Similarly, Alegre et al. [5] noticed a decrease in im-munoreactive AT III immediately after hemodialysis. This is also in contrast to our reports of unchanged immunoreative AT III and AT III activity during hemo-dialyis using several different hemodialysis membranes [8] . The reasons for these conflicting findings are not readily apparent, but our results are supported by other investigators [9] . In summary, our findings document a decreased protein C activity, despite normal antigen levels, in advanced renal failure which should be added to the list of hemo-static abnormalities afflicting these patients. A dialyzable inhibitor impairing protein C activity or causing a defect in its dicarboxylation is the most probable cause, but final elucidation of its nature awaits further studies.
